Immune‐related hepatobiliary adverse events associated with mogamulizumab: A case series and literature review
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 17.11.2026
DOI: 10.1111/ddg.70572x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 17.11.2026. Verfasst von Inga Hansen-Abeck und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Mogamulizumab is a monoclonal antibody targeting CC‐chemokine receptor‐4 that is approved as a second‐line therapy for mycosis fungoides and Sézary syndrome. The most common adverse events include infusion‐related reactions and mogamulizumab‐associated rash. Conversely, solid organ involvement in immune‐related adverse events has been limited to sporadic reports. Regarding mogamulizumab, hepatobiliary complications appear to occur predominantly alongside the reactivation of viral hepatitis. As management differs substantially from that of infectious hepatitis and immune‐mediated adverse events involving solid organs are potentially life‐threatening, their early recognition and attribution to mogamulizumab therapy are of high clinical importance. Treatment depends on severity, and interruption of therapy may be required. We report five cases of non‐infectious hepatobiliary adverse events during mogamulizumab treatment and summarize the current state of the literature. The aim is to emphasize the importance of early recognition of immune‐mediated toxicities affecting solid organs during mogamulizumab therapy in the management of patients with cutaneous lymphomas.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
- MVZ Dermatopathologie Duisburg Essen GmbH, Essen, Germany.
- Department of Dermatology and Venereology, Vivantes Klinikum Neukölln, Berlin, Germany.
- Department of Dermatology and Venereology, University Hospital Würzburg, Würzburg, Germany.
- Department of Dermatology and Venereology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.
- Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany.
ORCID-Profile: Inga Hansen-Abeck, Marion Wobser
Zitieren
APA
Hansen-Abeck, I., Hillen, U., Wobser, M., Mengoni, M., Eisert, L., Schneider, S. W., & Booken, N. (2026). Immune‐related hepatobiliary adverse events associated with mogamulizumab: A case series and literature review. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.70572x
Vancouver
Hansen-Abeck I, Hillen U, Wobser M, Mengoni M, Eisert L, Schneider SW, et al. Immune‐related hepatobiliary adverse events associated with mogamulizumab: A case series and literature review. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2026. doi:10.1111/ddg.70572x
BibTeX
@article{HansenAbeck2026,
author = {Hansen-Abeck, Inga and Hillen, Uwe and Wobser, Marion and Mengoni, Miriam and Eisert, Lisa and Schneider, Stefan W and Booken, Nina},
title = {Immune‐related hepatobiliary adverse events associated with mogamulizumab: A case series and literature review},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2026},
doi = {10.1111/ddg.70572x}
}
EUVIMED